BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 3126751)

  • 1. High density lipoprotein (HDL) subfractions in cardiovascular patients with low levels of HDL-cholesterol. Influence of hypertriglyceridaemia on subfraction concentration and composition.
    Hong ML; James RW; Grab B; Pometta D
    Atherosclerosis; 1988 Feb; 69(2-3):241-8. PubMed ID: 3126751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of cholesterol concentrations in low-density lipoprotein, high-density lipoprotein, and high-density lipoprotein subfractions, and of apolipoproteins AI and AII, with coronary stenosis and left ventricular function.
    Kempen HJ; van Gent CM; Buytenhek R; Buis B
    J Lab Clin Med; 1987 Jan; 109(1):19-26. PubMed ID: 3098880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperthyroidism influences the distribution and apolipoprotein A composition of the high density lipoproteins in man.
    Muls E; Rosseneu M; Bury J; Stul M; Lamberigts G; De Moor P
    J Clin Endocrinol Metab; 1985 Nov; 61(5):882-9. PubMed ID: 3930554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Whole-plasma and high-density lipoprotein subfraction surface lipid composition in IDDM men.
    Bagdade JD; Subbaiah PV
    Diabetes; 1989 Oct; 38(10):1226-30. PubMed ID: 2507376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of lovastatin and gemfibrozil on high-density lipoprotein subfraction density and composition in patients with familial hypercholesterolemia.
    Tilly-Kiesi M; Tikkanen MJ
    J Lab Clin Med; 1992 Jul; 120(1):103-10. PubMed ID: 1613316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipid and apoprotein modifications in body builders during and after self-administration of anabolic steroids.
    Baldo-Enzi G; Giada F; Zuliani G; Baroni L; Vitale E; Enzi G; Magnanini P; Fellin R
    Metabolism; 1990 Feb; 39(2):203-8. PubMed ID: 2105436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of serum lipids and high-density lipoprotein subfractions (HDL2, HDL3) in postmenopausal patients with breast cancer.
    Michalaki V; Koutroulis G; Syrigos K; Piperi C; Kalofoutis A
    Mol Cell Biochem; 2005 Jan; 268(1-2):19-24. PubMed ID: 15724433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High density lipoprotein subfractions during semistarvation in obese women.
    Bosello O; Cominacini L; Zocca I; Garbin U; Davoli A; Ferrari F
    Ann Nutr Metab; 1985; 29(6):381-6. PubMed ID: 3933405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Change in composition of high density lipoprotein during gemfibrozil therapy.
    Sorisky A; Ooi TC; Simo IE; Meuffels M; Hindmarsh JT; Nair R
    Atherosclerosis; 1987 Oct; 67(2-3):181-9. PubMed ID: 3118893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between plasma phospholipase A2 concentrations and lipoprotein subfractions in patients with stable coronary artery disease.
    Xu RX; Zhang Y; Li XL; Li S; Guo YL; Dong Q; Liu G; Li JJ
    Clin Chim Acta; 2015 Jun; 446():195-200. PubMed ID: 25934512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High density lipoprotein cholesterol subfractions in older people.
    Ettinger WH; Verdery RB; Wahl PW; Fried LP
    J Gerontol; 1994 May; 49(3):M116-22. PubMed ID: 8169333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations of resting heart rate with concentrations of lipoprotein subfractions in sedentary men.
    Williams PT; Haskell WL; Vranizan KM; Blair SN; Krauss RM; Superko HR; Albers JJ; Frey-Hewitt B; Wood PD
    Circulation; 1985 Mar; 71(3):441-9. PubMed ID: 3918806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between lipoprotein subfraction cholesterol and residual risk for cardiovascular outcomes: A post hoc analysis of the AIM-HIGH trial.
    Toth PP; Jones SR; Slee A; Fleg J; Marcovina SM; Lacy M; McBride R; Boden WE
    J Clin Lipidol; 2018; 12(3):741-747.e11. PubMed ID: 29627296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HDL subpopulations containing apoA-I without apoA-II (LpA-I) in patients with angiographically proven coronary artery disease.
    Kuchta A; Strzelecki A; Ćwiklińska A; Gruchała M; Zdrojewski Z; Kortas-Stempak B; Wieczorek E; Gliwińska A; Dąbkowski K; Jankowski M
    J Cardiol; 2017 Mar; 69(3):523-528. PubMed ID: 27169356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Free cholesterol concentrations in the high-density lipoprotein subfraction-3 as a risk indicator in patients with angiographically documented coronary artery disease.
    Smuts CM; Weich HF; Weight MJ; Faber M; Kruger M; Lombard CJ; Benadé AJ
    Coron Artery Dis; 1994 Apr; 5(4):331-8. PubMed ID: 8044345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-Density Lipoprotein Subfractions and Their Oxidized Subfraction Particles in Patients with Chronic Kidney Disease.
    Honda H; Hirano T; Ueda M; Kojima S; Mashiba S; Hayase Y; Michihata T; Shibata T
    J Atheroscler Thromb; 2016; 23(1):81-94. PubMed ID: 26289085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes of HDL subfraction concentration and particle size by intralipid in vivo.
    Sakuma N; Lin C; Matsumoto Y; Ikeuchi R; Ichikawa T; Hirata H; Noguchi Y; Fujinami T
    Atherosclerosis; 1988 Nov; 74(1-2):91-8. PubMed ID: 3145750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship of high density lipoprotein composition to plasma lecithin:cholesterol acyltransferase concentration in men.
    Miller NE; Rajput-Williams J; Nanjee MN; Samuel L; Albers JJ
    Atherosclerosis; 1988 Feb; 69(2-3):123-9. PubMed ID: 3126747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-density lipoprotein subfractions, apolipoproteins and antipyrine clearance in normal subjects.
    Luoma PV; Rautio A; Stengård J; Sotaniemi EA; Marniemi J
    Eur J Clin Pharmacol; 1990; 38(6):625-7. PubMed ID: 2373138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High density-lipoprotein subfractions of patients using cardio-selective beta-blockers.
    Kuster GM; Amann FW; Neuenschwander C; Drexel H
    Cardiovasc Drugs Ther; 2002 Mar; 16(2):127-31. PubMed ID: 12090905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.